News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Squarer Ron
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Squarer Ron (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 13,500 options to buy
@ $17.11, valued at
$231k
|
|
| 01/19/2023 |
4
| Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 3,269 options to buy
@ $21.27, valued at
$69.5k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 9,570 options to buy
@ $8.27, valued at
$79.1k
|
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 1,563 options to buy
@ $50.07, valued at
$78.3k
|
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $56.46, valued at
$677.5k
|
|
| 05/19/2020 |
4
| Squarer Ron (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 9,000 options to buy
@ $15.43, valued at
$138.9k
|
|
| 02/20/2020 |
4/A
| Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 21,900 options to buy
@ $51.85, valued at
$1.1M
|
|
| 12/06/2019 |
4
| Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 24,000 options to buy
@ $51.85, valued at
$1.2M
|
|
| 12/06/2019 |
3
| Squarer Ron (Director) has filed a Form 3 on Deciphera Pharmaceuticals, Inc. |
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2019 |
4
| Squarer Ron (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,000 shares
@ $0
Granted 8,000 options to buy
@ $17.94, valued at
$143.5k
|
|
| 04/03/2019 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 16,631 shares
@ $24.6, valued at
$409.1k
Exercised 18,907 restricted stock units
@ $0
Exercised 18,906 restricted stock units
@ $0 |
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2018 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 21,303 shares
@ $15.97, valued at
$340.2k
Granted 113,125 restricted stock units
@ $0
Granted 678,750 options to buy
@ $0
Exercised 23,437 restricted stock units
@ $0
Exercised 25,000 restricted stock units
@ $0 |
|
| 06/29/2018 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 34,253 shares
@ $18.5, valued at
$633.7k
Sold 43,628 shares
@ $17.74, valued at
$774k
Sold 140,625 shares
@ $18.03, valued at
$2.5M
Exercised 77,881 restricted stock units
@ $0
Exercised 140,625 options to buy
@ $8.79, valued at
$1.2M
|
|
| 05/11/2018 |
4
| Squarer Ron (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $26.52, valued at
$265.2k
|
|
| 04/03/2018 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 16,605 shares
@ $16.32, valued at
$271k
Exercised 18,906 restricted stock units
@ $0 |
|
| 12/19/2017 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 10,917 shares
@ $10.92, valued at
$119.2k
Sold 273,438 shares
@ $10.73, valued at
$2.9M
Sold 546,233 shares
@ $10.93, valued at
$6M
Exercised 23,437 restricted stock units
@ $0
Granted 100,000 restricted stock units
@ $0
Granted 600,000 options to buy
@ $10.92, valued at
$6.6M
Exercised 226,874 options to buy
@ $7.3, valued at
$1.7M
Exercised 16,835 options to buy
@ $5.94, valued at
$100k
Exercised 110,800 options to buy
@ $3.61, valued at
$400k
Exercised 133,380 options to buy
@ $3.61, valued at
$481.5k
Exercised 79,688 options to buy
@ $4.63, valued at
$369k
|
|
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/06/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/07/2013 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 350,000 options to buy
@ $5.94, valued at
$2.1M
|
|
| 10/05/2012 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 4,397 shares
@ $0 |
|
| 04/30/2012 |
3
| Squarer Ron (CEO) has filed a Form 3 on ARRAY BIOPHARMA INC |
| 02/28/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|